About Microarray
A microarray is an advanced tool used in molecular biology. It allows end-users to conduct high-throughput and highly parallel analyses of more than thousand points of interest that include messenger ribonucleic acid (mRNA), genes, and proteins. Microarrays include a broad range of platforms in which high-density assays are conducted parallel on a solid support. The concept of the microarray is based on base-pairing hybridization principle (hybridization between nucleic acids).
Technavio’s analysts forecast the global microarray market to grow at a CAGR of 14.34% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global microarray market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of microarray solutions such as instruments and consumables.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Microarray Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Agilent Technologies
• Illumina
• Thermo Fisher Scientific
• Merck
Other prominent vendors
• Applied Microarrays
• Arrayit
• AXO Science
• BioCat
• BioGenex
• Biometrix Technology
• Cepheid
• GE Healthcare
• InDevR
• LC Sciences
• Perkin Elmer
• Phalanx Biotech
• Qiagen
• Takara Bio
• US Biomax.
Market driver
• Increased prevalence of chronic diseases
• For a full, detailed list, view our report
Market challenge
• High cost of instruments
• For a full, detailed list, view our report
Market trend
• Rising focus on drug discovery and development
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Vendor analysis
• Top vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Market scenario
• Market size and forecast
• Five forces analysis
PART 05: Market landscape
• Market overview
PART 06: Geographical segmentation
• Market overview
PART 07: Market segmentation by application
• Market overview
PART 08: Market segmentation by product type
• Market overview
• Global microarray consumables market
• Global microarray instruments market
PART 09: Market segmentation by technology
• Segmentation by technology
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendor analysis
• Agilent Technologies
• Illumina
• Thermo Fisher Scientific
• Merck
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Key countries
Exhibit 02: Global microarray market segmentation: Overview
Exhibit 03: Snapshot of global microarray market
Exhibit 04: Global microarray market: Key impacting factors
Exhibit 05: Growth perspective in developed and developing markets
Exhibit 06: Key microarray technologies
Exhibit 07: Key pointers in the global microarray market
Exhibit 08: Market scenario and their impacting factors
Exhibit 09: Global microarray market 2015-2020 ($ billions)
Exhibit 10: Impact of various factors on global microarray market
Exhibit 11: Five forces analysis
Exhibit 12: Advantages of microarrays
Exhibit 13: Steps involved in microarray analysis
Exhibit 14: Applications of DNA microarrays
Exhibit 15: Global microarray market segmentation by geography 2015-2020
Exhibit 16: Snapshot of geographical segmentation 2015-2020
Exhibit 17: Microarray market in Americas 2015-2020 ($ billions)
Exhibit 18: Key leading countries
Exhibit 19: Microarray market in EMEA 2015-2020 ($ billions)
Exhibit 20: Key leading countries
Exhibit 21: Microarray market in APAC 2015-2020 ($ billions)
Exhibit 22: Key leading countries
Exhibit 23: Global microarray market segmentation by application 2015 and 2020
Exhibit 24: Global microarray market application segmentation by share 2015-2020 (% share)
Exhibit 25: Snapshot: Global microarray market by application
Exhibit 26: Global microarray market in gene expression segment 2015-2020 ($ billions)
Exhibit 27: Global microarray market in disease diagnosis and drug development segment 2015-2020 ($ billions)
Exhibit 28: Global microarray market in other segments 2015-2020 ($ billions)
Exhibit 29: Global microarray market segmentation by product type 2015 and 2020
Exhibit 30: Global microarray market segmentation by product type 2015-2020 (% share)
Exhibit 31: Global microarray consumables market 2015-2020 ($ billions)
Exhibit 32: Global microarray instruments market 2015-2020 ($ billions)
Exhibit 33: Value-chain of microarray instrument
Exhibit 34: Global microarray market segmentation by technology 2015 and 2020
Exhibit 35: Change in world population by age in years 2010-2050
Exhibit 36: Impact of drivers
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Region-wise growth in R&D spending in biomedical sector 2010-2015
Exhibit 39: Expected cancer cases and deaths by 2030
Exhibit 40: Strategic success factor of companies
Exhibit 41: Competitive parameters in global microarray market
Exhibit 42: Agilent Technologies profile
Exhibit 43: Agilent Technologies strength analysis
Exhibit 44: Agilent Technologies growth strategy matrix
Exhibit 45: Agilent Technologies: Opportunity assessment
Exhibit 46: Illumina profile
Exhibit 47: Illumina strength analysis
Exhibit 48: Illumina growth strategy matrix
Exhibit 49: Illumina: Opportunity assessment
Exhibit 50: Thermo Fisher Scientific profile
Exhibit 51: Thermo Fisher Scientific strength analysis
Exhibit 52: Thermo Fisher Scientific growth strategy matrix
Exhibit 53: Thermo Fisher Scientific: Opportunity assessment
Exhibit 54: Merck profile
Exhibit 55: Merck strength analysis
Exhibit 56: Merck growth strategy matrix
Exhibit 57: Merck: Opportunity assessment
